ReShape Lifesciences Inc. (RSLS) Share Price Today, Stock Analysis, Annual Report | Value Research ReShape Lifesciences Inc. (RSLS) - Get live share price today, stock analysis, price valuation, performance, fundamentals, market cap, share holding, financial report of US stocks.

ReShape Lifesciences Inc. (RSLS)

Download Stock Report

NASDAQ: RSLS

  • Price Change
  • Market Capitalisation market-capitalisation-info $7 Mln

  • 12 Month Earnings monthly-earning $-21 Mln
  • Price to Earnings price-to-earning --

ReShape Lifesciences Inc. (RSLS) Share Price

$0.61

As on 22-Sep-2023 15:59 EDT

up-down-arrow $0.000.25%

  • Prev Close info

    $0.61

  • Day's Openinfo

    $0.61

  • Today's Highinfo

    $0.66

  • Today's Lowinfo

    $0.59

  • Today's Volumeinfo

    29,957

Please wait...

ReShape Lifesciences Inc. (RSLS) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
ReShape Lifesciences (RSLS)
-90.91 -48.93 -69.81 -96.34 -83.31 -82.68 -55.26
S&P BSE Sensex*
8.52 1.18 4.83 13.64 21.78 12.71 12.73
#
-- -- -- -- -- -- --
As on 22-Sep-2023  |  *As on 25-Sep-2023  |  #As on
2022
2021
2020
2019
2018
2017
2016
ReShape Lifesciences (RSLS)
-91.78 -53.80 -38.26 125.49 -82.60 -26.00 1,437.28
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

ReShape Lifesciences Inc. (RSLS) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of ReShape Lifesciences Inc. (RSLS)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Exec. Chair

        Mr. Dan W. Gladney

        Sr. VP of Fin. & CFO

        Mr. Thomas Stankovich

        Headquarters

        San Clemente, CA

        FAQs for ReShape Lifesciences Inc. (RSLS)

        The total asset value of ReShape Lifesciences Inc. (RSLS) stood at $ 13 Mln as on 31-Mar-23

        The share price of ReShape Lifesciences Inc. (RSLS) is $0.612800 (NASDAQ) as of 22-Sep-2023 15:59 EDT. ReShape Lifesciences Inc. (RSLS) has given a return of -83.31% in the last 3 years.

        ReShape Lifesciences Inc. (RSLS) has a market capitalisation of $ 7 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.

        The P/B ratio of ReShape Lifesciences Inc. (RSLS) is 0.16 times as on 02-Jun-2023, a -0.96% premium to its peers’ median range of 4.02 times.

        Since, TTM earnings of ReShape Lifesciences Inc. (RSLS) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the ReShape Lifesciences Inc. (RSLS) and enter the required number of quantities and click on buy to purchase the shares of ReShape Lifesciences Inc. (RSLS).

        ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

        The CEO & director of Mr. Dan W. Gladney. is ReShape Lifesciences Inc. (RSLS), and CFO & Sr. VP is Mr. Thomas Stankovich.

        The promoters of ReShape Lifesciences Inc. (RSLS) have pledged 0% of the total equity as on Mar-23.

        ReShape Lifesciences Inc. (RSLS) Ratios
        Return on equity(%)
        -443.92
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0

        No, TTM profit after tax of ReShape Lifesciences Inc. (RSLS) was $-21 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $7.41 Mln
        • Revenue (TTM)revenue-information $11.91 Mln
        • Earnings (TTM) earning-information $-21.39 Mln
        • Cash date-information $3.86 Mln
        • Total Debt info $0.17 Mln
        • Insider's Holding 5.62%
        • Liquidity liquidity High
        • 52 Week range week-range $0.57 - 22.40
        • Shares outstanding share-outstanding 2,942,310
        • 10 Years Aggregate:

          CFO: $-193.18 Mln

          EBITDA: $-295.26 Mln

          Net Profit: $-419.72 Mln

        About The Company

        • IPO Date 15-Nov-2007
        • Exec. Chair Mr. Dan W. Gladney
        • Sr. VP of Fin. & CFO Mr. Thomas Stankovich
        • Listing key-listing NASDAQ: RSLS
        • Country United States
        • Headquarters headquarters San Clemente, CA
        • Website website https://www.reshapelifesciences.com
        • Business

          ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band...  System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon